Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir

In 2012, the first-generation protease inhibitors telaprevir (TVR) and boceprevir (BOC) were introduced in the Brazilian health system for treatment of chronic hepatitis C, after their approval by the National Committee for Health Technology Incorporation (CONITEC). However, these medicines were dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomes, Lenyta Oliveira, Teixeira, Marina Rodrigues, da Rosa, Júnior André, Feltrin, Alberi Adolfo, Rodrigues, João Paulo V., Vecchi, Mariane D’Avila, Carneiro, Jane Meire M., Noblat, Lúcia de Araújo C. B., Chachá, Silvana Gama F., Martinelli, Ana de Lourdes C., Pereira, Leonardo Regis L., Silveira, Marysabel Pinto T., Blatt, Carine Raquel, Farias, Mareni Rocha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto de Medicina Tropical 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029893/
https://www.ncbi.nlm.nih.gov/pubmed/29972466
http://dx.doi.org/10.1590/S1678-9946201860029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029893/
https://www.ncbi.nlm.nih.gov/pubmed/29972466
http://dx.doi.org/10.1590/S1678-9946201860029

Ejemplares similares